全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication

DOI: 10.1177/1753944718786926

Keywords: therapeutic angiogenesis, gene therapy, VEGF165, intermittent claudication

Full-Text   Cite this paper   Add to My Lib

Abstract:

The effective treatment of chronic lower limb ischemia is one of the most challenging issues confronting vascular surgeons. Current pharmacological therapies play an auxiliary role and cannot prevent disease progression, and new treatment methods are needed. In 2011, a plasmid VEGF65-gene therapy drug was approved in Russia for the treatment of chronic lower limb ischemia (ClinicalTrials.gov identifier: {"type":"clinical-trial","attrs":{"text":"NCT03068585","term_id":"NCT03068585"}}NCT03068585). The objective of this follow-up study was to evaluate the long-term safety and efficacy of gene therapy in patients with limb ischemia of atherosclerotic genesis

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133